Invitrocue Clinical Studies underway in Germany

Invitrocue Clinical Studies underway in Germany

Innovative life sciences company Invitrocue Limited (ASX: IVQ) (‘Invitrocue’ or ‘the Company’) is pleased to announce that a clinical validation study is underway for its Onco-PDO test with Klinikum Rechts der Isar der Technischen Universitat Munchen, Comprehensive Cancer Center Munich, Germany.

invitrocue-clinical-validation-studies-underway-in-germany